18 August, 2026 | Tuesday | News

-JW Pharmaceutical (KRX:001060) announced that the multinational Phase 3 clinical trial of its gout treatment candidate ‘Epaminurad (code name URC102)’ demonstrated excellent serum uric acid-lo...

13 August, 2026 | Thursday | News

Olink™ Explore HT analysis of approximately 5,500 research samples completed, with data now available Key Facts Collaboration: Thermo Fisher Scientific and The Michael J. Fox Foundation expanded ...

18 August, 2026 | Tuesday | Analysis

Radioligand therapy is the one modality a region cannot buy its way into late. A vial of lutetium-177 loses half its therapeutic activity in roughly six and a half days. A vial of lead-212 loses half in under e...

12 August, 2026 | Wednesday | News

Expansion adds first BioReliance® Cell Line Characterization and GMP Next-Generation Sequencing in Asia Pacific Enhanced testing capabilities to deliver speed, sensitivity, and sustainability for bi...

10 August, 2026 | Monday | Opinion

Asia Pacific’s ageing economies are entering a more demanding phase of healthcare planning. As populations live longer, the challenge for healthcare systems is no longer only about extending life expectan...

13 August, 2026 | Thursday | News

VMS Group, a global alternative investment specialist, announced that its portfolio company, Ommo Technologies (Ommo), a spatial intelligence technology company, has completed a Series A financing rou...

18 August, 2026 | Tuesday | News

AbelZeta Pharma, Inc. ("AbelZeta" or the "Company"), a global clinical-stage biopharmaceutical company focused on the discovery and development of innovative and proprietary cell-based therapeutic products, tod...